Published in PLoS One on October 17, 2014
Concordance of Results from Randomized and Observational Analyses within the Same Study: A Re-Analysis of the Women's Health Initiative Limited-Access Dataset. PLoS One (2015) 0.76
Food science and food ingredients: the need for reliable scientific approaches and correct communication, Florence, 24 March 2015. Int J Food Sci Nutr (2015) 0.76
Long-Term Cohort Studies in Brazil: On the Tracks of the Nurses' Health Study and Beyond. Am J Public Health (2016) 0.75
Medical big data: promise and challenges. Kidney Res Clin Pract (2017) 0.75
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA (2002) 80.37
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA (2004) 23.69
Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med (2000) 19.56
The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med (1994) 16.96
A comparison of observational studies and randomized, controlled trials. N Engl J Med (2000) 14.11
Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. JAMA (2005) 12.09
Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med (2006) 11.72
Why most discovered true associations are inflated. Epidemiology (2008) 11.22
The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med (1995) 11.08
Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med (1996) 10.09
Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med (2006) 9.53
Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA (2005) 9.03
Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. N Engl J Med (1991) 8.66
Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ (2002) 7.14
Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA (1998) 7.09
Those confounded vitamins: what can we learn from the differences between observational versus randomised trial evidence? Lancet (2004) 6.37
When are observational studies as credible as randomised trials? Lancet (2004) 6.19
Comparison of evidence of treatment effects in randomized and nonrandomized studies. JAMA (2001) 5.96
Vitamin E consumption and the risk of coronary disease in women. N Engl J Med (1993) 5.39
A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med (2000) 5.17
Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med (2000) 5.09
Aspirin intake and survival after breast cancer. J Clin Oncol (2010) 4.50
Can dietary beta-carotene materially reduce human cancer rates? Nature (1981) 4.43
Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' Health Study. Am J Epidemiol (2000) 3.94
A prospective study of aspirin use and primary prevention of cardiovascular disease in women. JAMA (1991) 3.67
Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA (2002) 3.60
Fish and long-chain omega-3 fatty acid intake and risk of coronary heart disease and total mortality in diabetic women. Circulation (2003) 3.50
Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med (1996) 3.35
A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med (1985) 3.21
Beyond randomised versus observational studies. Lancet (2004) 3.11
Dietary intake of alpha-linolenic acid and risk of fatal ischemic heart disease among women. Am J Clin Nutr (1999) 3.03
Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation. J Womens Health (Larchmt) (2006) 2.77
Serum lipids, lipid-lowering drugs, and the risk of breast cancer. Arch Intern Med (2005) 2.66
Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst Rev (2009) 2.58
Prospective study of regular aspirin use and the risk of breast cancer. J Natl Cancer Inst (1996) 2.58
Prospective study of estrogen replacement therapy and risk of breast cancer in postmenopausal women. JAMA (1990) 2.45
Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50,000 individuals. Lancet (2013) 2.37
Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiol Biomarkers Prev (2005) 2.37
Intake of dairy products, calcium, and vitamin d and risk of breast cancer. J Natl Cancer Inst (2002) 2.16
A prospective study of the intake of vitamins C, E, and A and the risk of breast cancer. N Engl J Med (1993) 2.15
Calcium, vitamin D, milk consumption, and hip fractures: a prospective study among postmenopausal women. Am J Clin Nutr (2003) 1.84
A prospective study of folate intake and the risk of breast cancer. JAMA (1999) 1.83
Bias in the evaluation of low-magnitude associations: an empirical perspective. Am J Epidemiol (2000) 1.76
Plasma carotenoids, retinol, and tocopherols and risk of breast cancer. Am J Epidemiol (2005) 1.56
Safety and tolerability of pravastatin in long-term clinical trials: prospective Pravastatin Pooling (PPP) Project. Circulation (2002) 1.51
Postmenopausal hormone use and secondary prevention of coronary events in the nurses' health study. a prospective, observational study. Ann Intern Med (2001) 1.44
Vitamin K intake and hip fractures in women: a prospective study. Am J Clin Nutr (1999) 1.41
Unopposed estrogen therapy and the risk of invasive breast cancer. Arch Intern Med (2006) 1.40
False alarms and pseudo-epidemics: the limitations of observational epidemiology. Obstet Gynecol (2012) 1.38
Aspirin for the prevention of cardiovascular events in patients without clinical cardiovascular disease: a meta-analysis of randomized trials. Am Heart J (2011) 1.35
COX-2 expression predicts worse breast cancer prognosis and does not modify the association with aspirin. Breast Cancer Res Treat (2011) 1.22
Beta-carotene supplementation and cancer risk: a systematic review and metaanalysis of randomized controlled trials. Int J Cancer (2010) 1.21
Carotenoid intakes and risk of breast cancer defined by estrogen receptor and progesterone receptor status: a pooled analysis of 18 prospective cohort studies. Am J Clin Nutr (2012) 1.21
Omega 3 Fatty acids and cardiovascular outcomes: systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes (2012) 1.21
Folate intake and risk of breast cancer characterized by hormone receptor status. Cancer Epidemiol Biomarkers Prev (2005) 1.15
Milk, dietary calcium, and bone fractures in women: a 12-year prospective study. Am J Public Health (1997) 1.08
Dietary carotenoids and risk of coronary artery disease in women. Am J Clin Nutr (2003) 1.00
Looking to the 21st century: have we learned from our mistakes, or are we doomed to compound them? Pharmacoepidemiol Drug Saf (2004) 0.98
Observational studies often make clinical practice recommendations: an empirical evaluation of authors' attitudes. J Clin Epidemiol (2013) 0.98
Calcium supplements and cancer risk: a meta-analysis of randomised controlled trials. Br J Nutr (2013) 0.96
Use of postmenopausal hormones and risk of myocardial infarction. Circulation (1981) 0.96
Type of postmenopausal hormone use and risk of breast cancer: 12-year follow-up from the Nurses' Health Study. Cancer Causes Control (1992) 0.95
Vitamin K to prevent fractures in older women: systematic review and economic evaluation. Health Technol Assess (2009) 0.92
Effects of treatment with fluoride on bone mineral density and fracture risk--a meta-analysis. Osteoporos Int (2007) 0.90
Calcium risk-benefit updated--new WHI analyses. Maturitas (2013) 0.87
Vitamin D supplementation and breast cancer prevention: a systematic review and meta-analysis of randomized clinical trials. PLoS One (2013) 0.87
Effect of hormone replacement therapy on cardiovascular outcomes: a meta-analysis of randomized controlled trials. PLoS One (2013) 0.82
Use of toenail fluoride levels as an indicator for the risk of hip and forearm fractures in women. Epidemiology (1998) 0.80
Vitamin D supplementation and falls: a trial sequential meta-analysis. Lancet Diabetes Endocrinol (2014) 2.85
Responses of specialist societies to evidence for reversal of practice. JAMA Intern Med (2015) 1.18
Calcium supplements increase risk of myocardial infarction. J Bone Miner Res (2015) 1.11
How common are symptoms? Evidence from a New Zealand national telephone survey. BMJ Open (2014) 1.09
Vitamin D Supplements and the Risk of Falls. JAMA Intern Med (2015) 1.09
Do vitamin D supplements help prevent respiratory tract infections? BMJ (2017) 0.95
Reporting of Limitations of Observational Research. JAMA Intern Med (2015) 0.88
Conflicts of interest and expertise of independent commenters in news stories about medical research. CMAJ (2016) 0.86
Everolimus and zoledronic acid in patients with renal cell carcinoma with bone metastases: a randomized first-line phase II trial. Clin Genitourin Cancer (2014) 0.84
Press releases issued by supplements industry organisations and non-industry organisations in response to publication of clinical research findings: a case-control study. PLoS One (2014) 0.82
Evidence for a role for the p110-alpha isoform of PI3K in skeletal function. Biochem Biophys Res Commun (2009) 0.82
Differences between self-reported and verified adverse cardiovascular events in a randomised clinical trial. BMJ Open (2013) 0.81
A comparison of adverse event and fracture efficacy data for strontium ranelate in regulatory documents and the publication record. BMJ Open (2014) 0.81
Calcium supplements and cardiovascular risk: 5 years on. Ther Adv Drug Saf (2013) 0.80
Duration of antiresorptive effects of low-dose zoledronate in osteopenic postmenopausal women: a randomized, placebo-controlled trial. J Bone Miner Res (2014) 0.80
Mendelian randomization analysis to examine for a causal effect of urate on bone mineral density. J Bone Miner Res (2015) 0.80
Randomised controlled trial of vitamin D supplementation in sarcoidosis. BMJ Open (2013) 0.80
Clinical trial evidence and use of fish oil supplements. JAMA Intern Med (2014) 0.78
Skeletal health in adults with HIV infection. Lancet Diabetes Endocrinol (2014) 0.78
Management recommendations for osteoporosis in clinical guidelines. Clin Endocrinol (Oxf) (2016) 0.77
Concordance of Results from Randomized and Observational Analyses within the Same Study: A Re-Analysis of the Women's Health Initiative Limited-Access Dataset. PLoS One (2015) 0.76
Perceptions of generic medication in the general population, doctors and pharmacists: a systematic review. BMJ Open (2015) 0.76
Tyrosine Kinase Inhibitors Regulate OPG through Inhibition of PDGFRβ. PLoS One (2016) 0.75
Randomised trial assessing the impact of framing of fracture risk and osteoporosis treatment benefits in patients undergoing bone densitometry. BMJ Open (2017) 0.75
Calcium supplements associated with increased risk of cardiovascular death in men but not women. Evid Based Nurs (2013) 0.75
Benefits of vitamin d? Am J Med (2010) 0.75
Benefits of calcium supplements are too small for clinical equipoise to exist. J Bone Miner Res (2014) 0.75
The Impact of 3-D Models versus Animations on Perceptions of Osteoporosis and Treatment Motivation: A Randomised Trial. Ann Behav Med (2017) 0.75
Republished: Paget's disease of bone: clinical review and update. Postgrad Med J (2014) 0.75
Long-Term Stable Bone Mineral Density in HIV-Infected Men Without Risk Factors for Osteoporosis Treated with Antiretroviral Therapy. Calcif Tissue Int (2019) 0.75
Lysophosphatidic Acid Is an Osteoblast Mitogen Whose Proliferative Actions Involve Gi Proteins and Protein Kinase C, But Not P42/44 Mitogen-Activated Protein Kinases. Endocrinology (2001) 0.75
Calcium and Cardiovascular Disease. Endocrinol Metab (Seoul) (2017) 0.75
Duration of antiresorptive activity of zoledronate in postmenopausal women with osteopenia: a randomized, controlled multidose trial. CMAJ (2017) 0.75
Reporting of conflicts of interest in oral presentations at medical conferences: a delegate-based prospective observational study. BMJ Open (2017) 0.75